Companies /Healthcare

Elevance Health Inc

NYSE: ELV Healthcare Plans
$390.16
▼ $10.68 (−2.66%) today
Markets closed · 4:53pm ET

24/7 Wall St. View

ELV at a Glance

Valuation
Market cap
$90.7B
P/E ratio
17.8
Dividend yield
1.58%
Profitability
Revenue (TTM)
$201.8B
Profit margin
2.6%
EPS (TTM)
$23.55
Price
52-week range
$271 – $451
24/7 target
$603.18
Street target
$482.38

Headquartered in Indianapolis, IN Fiscal year ends December NYSE: ELV elevancehealth.com

About Elevance Health

Elevance Health, Inc. (NYSE: ELV) is a diversified health services company that serves approximately 104 million consumers through a portfolio of medical, pharmacy, behavioral, clinical, home health, and complex care solutions. The company operates through four reportable segments: Health Benefits (encompassing Individual/ACA, Employer Group risk-based and fee-based, BlueCard, Medicare, Medicaid, and Federal Employee Program businesses), CarelonRx (pharmacy services including specialty pharmacy), Carelon Services (healthcare services and risk-based care solutions), and Corporate & Other. As of June 30, 2026, Elevance Health had approximately 44.9 million medical members. The company is a Blue Cross Blue Shield licensee and is focused on medical cost management, member experience, provider connectivity, operating efficiency, and value-based care through its Carelon platform. Updated

Latest Activity

Anthropic IPO, Fed Shock Talk and Health Insurer Sell-Off

  • Waller's talk of a 50bp December hike, a 19-month-high dollar and falling oil have Tim Seymour flagging an unpriced growth scare
  • Anthropic priced at $83, roughly a $1.5 trillion valuation and the largest IPO ever; Gil Luria expects a $100 day-one pop
  • Luria: the whole AI capex cycle rides on the deal working, with Amazon, Google and Broadcom most exposed
  • Proposed CRUSH health rules drove double-digit drops in UnitedHealth, Humana and Centene; Mike Coe would sell premium to get long UNH

Rate hike risk and collapsing commodities matter more right now than Nvidia's quarter. Anthropic's IPO debut becomes a referendum on AI spending itself, with Luria urging patience on entry given no comparables. Palo Alto beat and raised with 66% next-gen security ARR growth, yet Seymour still calls cybersecurity valuations too rich to chase.

Biggest movers · At the close
  • SSentinelOne$23.42+10.8%
  • PANWPalo Alto Networks$338.12+9.3%
  • OPENOpendoor Technologies$1.29+8.9%
  • TJXTJX Companies$140.72+8.4%
  • CRWDCrowdStrike$237.86+8.3%
  • IQiQIYI$0.59-16.5%
  • UNHUnitedHealth Group$350.75-10.0%
  • AAOIApplied Optoelectronics$40.79-9.8%
  • ELVElevance Health$401.67-7.5%
  • APPSDigital Turbine$6.52-7.4%

Cybersecurity took the close, with SentinelOne up 10.8% and CrowdStrike and Palo Alto Networks both above 8%, the latter alongside its fiscal Q1 2027 earnings. Managed care ran the opposite way, UnitedHealth down 10% and Elevance down 7.4%.

CLOVClover Health
Regular session
$4.30
-8.60%off the open $4.71

An 8.6% slide to $4.31 came alongside declines across managed care: Humana fell 8.46%, Elevance 6.27% and CVS 3.19% in the same session. These names are moving together today.

Related stockstoday
  • HUMHumanaCompetitor-8.5%
    Dec 31, 2025 · SEC 10-K · Nov 18, 12:00 PM ET · Alpha Vantage quote
  • ELVElevance HealthCompetitor-6.3%
    Dec 31, 2025 · SEC 10-K · Nov 18, 2:20 PM ET · Alpha Vantage quote
  • CVSCVS HealthCompetitor-3.2%
    Feb 27, 8:08 AM ET · SEC 10-K · Nov 18, 2:20 PM ET · Alpha Vantage quote

2 more related stocks · 4 have no US listing

ELVElevance Health
52-week high
$446.42
+0.26%vs prior 52-week high · Oct 22, 2026

Elevance Health closed at a fresh one-year high of $446.42, 0.26% above its prior peak set on October 22. Competitor Clover Health slipped 0.2% on the day.

Related stockstoday

Moves: Nov 16, 2026 · Alpha Vantage daily close

2 have no US listing

Biggest movers · At the close
  • BILLBill Holdings$57.31+5.2%
  • ELVElevance Health$446.11+3.8%
  • HUMHumana$462.49+2.7%
  • DUOLDuolingo$169.56+2.6%
  • HCAHCA Healthcare$511.55+2.5%
  • IQiQIYI$0.69-17.3%
  • NVTSNavitas Semiconductor$7.9-11.8%
  • IRENIREN$16.35-10.0%
  • AAOIApplied Optoelectronics$44.95-9.9%
  • TEMTempus AI$64.65-9.7%

Sellers controlled the close, with iQIYI down 17.27% on the day it filed third quarter results and no gainer topping a fraction of that. Healthcare took the top three slots after Bill Holdings.

Biggest movers · On the open
  • ELVElevance Health$443.16+3.1%
  • HCAHCA Healthcare$512.29+2.7%
  • SBUXStarbucks$109.09+2.5%
  • ARGXargenx$980.72+2.1%
  • GILDGilead Sciences$171.55+2.1%
  • IQiQIYI$0.71-14.7%
  • ASXASE Technology Holding$32.44-8.7%
  • SNDKSanDisk$808.84-8.6%
  • COHRCoherent$199.62-8.5%
  • LITELumentum$545.81-8.5%

Healthcare is leading at the open while AI hardware lags: SanDisk, Coherent, Lumentum and ASE Technology are all down roughly 8.5% or more, with Elevance, HCA and Gilead on the upside. iQIYI drops 14.7% after filing its third-quarter earnings report this morning.

CLOVClover Health
After-hours
$4.82
+9.05%off the open $4.42

The 9.05% run came the same day Humana, a competitor, posted Q3 2026 results. Managed care names moved together into the close.

Before the movelast 24 hours
  1. Earnings release
    Related company: HUM, competitor

    Humana Q3 2026 earnings release

Related stockstoday

Moves: Nov 6, 4:20 PM ET · Alpha Vantage quote

3 more related stocks · 4 have no US listing

Sold Elevance Health, Inc.$1M2,343 shares @ $441.34

Elevance's CFO cut roughly a third of his reported common stock in one day, selling 10,584 shares for about $4.65 million into prices as high as $447.19. No 10b5-1 plan is flagged, which makes this a discretionary exit by the person who knows the Medicare Advantage cost math best.

ELVElevance Health
Regular session
$426.70
-4.38%open $446.25

The managed-care insurer heads into today's earnings report already on the back foot, down 4.38% on the day. That slide sets a low bar for how the report lands.

ELVElevance Health, Inc.
Reports Wed Oct 21Before openConfirmed

Elevance reports before the open at 6:00 AM ET with four straight EPS beats behind it, the last one topping estimates by 20.6%. Consensus sits at $4.69 on $49.16 billion in revenue, and Medicare Advantage cost trends are the line that decides how insurers trade today.

    ELV Coverage

    Frequently Asked Questions

    What does Elevance Health do?

    Elevance Health, Inc. (NYSE: ELV) is a diversified health services company that serves approximately 104 million consumers through a portfolio of medical, pharmacy, behavioral, clinical, home health, and complex care solutions.

    What is the ELV stock price target?

    24/7 Wall St.'s 12-month price target for ELV is $603.18, rated Buy. The Wall Street consensus target is $482.38. ELV price prediction →